Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Teladoc Health Inc., 3 years.
Teladoc Health Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Surgery Partners Inc. | Open-market sale | −20,400 | $12.47 | $254,388 |
| Mar 6, 2026 | Surgery Partners Inc. | Open-market sale | −11,462 | $13.79 | $158,061 |
| Mar 5, 2026 | Surgery Partners Inc. | Grant or award | +141,743 | $14.11 | $1,999,994 |
| Mar 5, 2026 | Surgery Partners Inc. | Grant or award | +136,363 | $14.11 | $1,924,082 |
| Dec 19, 2025 | Teladoc Health Inc. | Option exercise | +1,016 | — | — |
| Sep 19, 2025 | Teladoc Health Inc. | Option exercise | +1,016 | — | — |
| Jun 20, 2025 | Teladoc Health Inc. | Option exercise | +1,016 | — | — |
| Mar 20, 2025 | Teladoc Health Inc. | Option exercise | +1,016 | — | — |
| Mar 4, 2025 | Surgery Partners Inc. | Grant or award | +84,033 | $23.80 | $1,999,985 |
| Mar 4, 2025 | Surgery Partners Inc. | Grant or award | +29,411 | $23.80 | $699,982 |
| Feb 7, 2025 | Surgery Partners Inc. | Open-market sale | −26,520 | $25.65 | $680,238 |
| Jan 31, 2025 | Surgery Partners Inc. | Grant or award | +111,048 | — | — |
| Dec 20, 2024 | Teladoc Health Inc. | Option exercise | +1,016 | — | — |
| Dec 12, 2024 | Surgery Partners Inc. | Option exercise | +16,500 | $11.54 | $190,410 |
| Sep 20, 2024 | Teladoc Health Inc. | Option exercise | +4,065 | — | — |
Questions about Jason Eric Evans
What boards is Jason Eric Evans on?
Jason Eric Evans sits on the board of Teladoc Health Inc.
How long has Jason Eric Evans served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.